Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003)
Sponsor: Merck Sharp & Dohme LLC
Summary
The goal of this study is to learn what happens to a single dose of enlicitide over time in a healthy participant's body when the participant is given a single dose of MK-7262 and what happens to a single dose of MK-7262 over time in a healthy participant's body when the participant is given a single dose of enlicitide.
Official title: A Clinical Drug-Drug Interaction Study to Evaluate the Mutual Pharmacokinetic Effects of MK-7262 and Enlicitide in Healthy Participants
Key Details
Gender
All
Age Range
19 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-07-06
Completion Date
2026-09-12
Last Updated
2026-06-02
Healthy Volunteers
Yes
Conditions
Interventions
MK-7262
Oral administration
Enlicitide
Oral administration